Last reviewed · How we verify
Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Caduet | Amlodipine Besylate | Pfizer Inc. | Dihydropyridine calcium channel blocker | L-type calcium channel |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer Inc. · 1 drug in Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD:
- Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD treatment updates — RSS
- Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD treatment updates — Atom
- Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD treatment updates — JSON
Cite this brief
Drug Landscape (2026). Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/multiple-risk-factors-for-coronary-heart-disease-chd-but-without-clinically-evident-chd. Accessed 2026-06-11.
Related
- Multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing